Posted by ABMN Staff on May 13th, 2024
2seventy bio, Inc. (NASDAQ:TSVT – Free Report) – Research analysts at Wedbush lifted their Q2 2024 earnings per share (EPS) estimates for 2seventy bio in a report released on Wednesday, May 8th. Wedbush analyst D. Nierengarten...
More of this article »